Related references
Note: Only part of the references are listed.Development of a reverse genetics system for Japanese encephalitis virus strain SA14-14-2
Guohua Li et al.
VIRUS GENES (2019)
Twenty Years of Progress Toward West Nile Virus Vaccine Development
Jaclyn A. Kaiser et al.
VIRUSES-BASEL (2019)
A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
Entao Li et al.
VIRUSES-BASEL (2019)
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
Christopher W. Woods et al.
VACCINE (2019)
A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers
Kristen K. Pierce et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
P. Noel Barrett et al.
EXPERT REVIEW OF VACCINES (2017)
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
Hang Chi et al.
VACCINE (2017)
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence
Alexander J. McAuley et al.
JOURNAL OF VIROLOGY (2016)
Serum Neutralization Assay Can Efficiently Replace Plaque Reduction Neutralization Test for Detection and Quantitation of West Nile Virus Antibodies in Human and Animal Serum Samples
Annapia Di Gennaro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2
Xiao-Feng Li et al.
JOURNAL OF GENERAL VIROLOGY (2013)
A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman Primates
Xiao-Feng Li et al.
JOURNAL OF VIROLOGY (2013)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Anna P. Durbin et al.
VACCINE (2013)
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age
Gustavo H. Dayan et al.
VACCINE (2012)
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Rex Biedenbender et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
Yongxin Yu
VACCINE (2010)
Modern Uses of Electron Microscopy for Detection of Viruses
Cynthia S. Goldsmith et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
Neuroadapted yellow fever virus 17D: Genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone
TJ Chambers et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
